Anushka Sengupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anushka Sengupta has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Amartya Saha
Cell Development and Immunobiology Laboratory, Department of Zoology, Netaji Subhas Open University, Kolkata, India, India
1 shared publication - Amitava Bandhu
Department of Biotechnology, National Institute of Technology Warangal, Warangal, India
1 shared publication - Anirban Ghosh
Cell Development and Immunobiology Laboratory, Department of Zoology, Netaji Subhas Open University, Kolkata, India, India
1 shared publication - Ayantika Pal
Department of Life Science, Shri Rawatpura Sarkar University, Raipur, India, India
1 shared publication - Dijendra Nath Roy
National Institute of Technology-Raipur
1 shared publication - Shouryadip Paul
Department of Biotechnology, National Institute of Technology, Raipur, India, India
1 shared publication
Latest Publications
- Open Access
- 12 November 2026
- Published by MDPI AG in Preprints.org
Enteric Neuroglia-Immune Axis in Dysbiosis: Modulating the Tripartite Cascade with Dietary Phytochemicals
The gastrointestinal tract is a dynamic regulatory interface in which the enteric nervous system (ENS), supported by an extensive enteric glial cell (EGC) network, interacts with the enteric immune system (EIS) and gut microbiota to maintain epithelial barrier integrity, neuroplasticity, motility, and tissue repair. In eubiosis, coordinated signaling across this tripartite axis supports intestinal homeostasis. Dysbiosis, however, can reduce short-chain fatty acid (SCFA) availability while increasing exposure to pathogen-associated molecular patterns (PAMPs), including lipopolysaccharide (LPS) and others. These changes may activate NF-κB and NLRP3 inflammasome signaling in enteric glial and immune cells, thereby promoting oxidative and nitrosative stress, neuronal hyperexcitability, apoptosis, barrier dysfunction, and local neuroinflammation, with possible consequences for gut–brain communication. This review examines the mechanisms through which dietary phytochemicals—including capsaicinoids, resveratrol, curcumin, catechins, quercetin, and sulforaphane—may modulate this ENS–EIS–microbiota axis. We focus on their actions at transient receptor potential channels, 5-hydroxytryptamine receptors, nicotinic acetylcholine receptors, SIRT1, and Nrf2-associated pathways, and their potential to limit inflammation, oxidative stress, and excitotoxic signaling. We also identify knowledge gaps and discuss future research and translational priorities, including human-relevant organoid models, spatial transcriptomics, and machine-learning-enabled multi-omics to define microbiota-derived metabolite–receptor interactions and guide personalized dietary strategies for enteric neuroglial health.
- 12 November 2026
- Published by MDPI AG in Preprints.org
Open AccessEnteric Neuroglia-Immune Axis in Dysbiosis: Modulating the Tripartite Cascade with Dietary Phytochemicals
The gastrointestinal tract is a dynamic regulatory interface in which the enteric nervous system (ENS), supported by an extensive enteric glial cell (EGC) network, interacts with the enteric immune system (EIS) and gut microbiota to maintain epithelial barrier integrity, neuroplasticity, motility, and tissue repair. In eubiosis, coordinated signaling across this tripartite axis supports intestinal homeostasis. Dysbiosis, however, can reduce short-chain fatty acid (SCFA) availability while increasing exposure to pathogen-associated molecular patterns (PAMPs), including lipopolysaccharide (LPS) and others. These changes may activate NF-κB and NLRP3 inflammasome signaling in enteric glial and immune cells, thereby promoting oxidative and nitrosative stress, neuronal hyperexcitability, apoptosis, barrier dysfunction, and local neuroinflammation, with possible consequences for gut–brain communication. This review examines the mechanisms through which dietary phytochemicals—including capsaicinoids, resveratrol, curcumin, catechins, quercetin, and sulforaphane—may modulate this ENS–EIS–microbiota axis. We focus on their actions at transient receptor potential channels, 5-hydroxytryptamine receptors, nicotinic acetylcholine receptors, SIRT1, and Nrf2-associated pathways, and their potential to limit inflammation, oxidative stress, and excitotoxic signaling. We also identify knowledge gaps and discuss future research and translational priorities, including human-relevant organoid models, spatial transcriptomics, and machine-learning-enabled multi-omics to define microbiota-derived metabolite–receptor interactions and guide personalized dietary strategies for enteric neuroglial health.